Animal Models and Therapeutic Molecules
US-2016345552-A1 · Dec 1, 2016 · US
US10994005B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10994005-B2 |
| Application number | US-201916771693-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 30, 2019 |
| Priority date | May 30, 2019 |
| Publication date | May 4, 2021 |
| Grant date | May 4, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A novel K (capsular antigen) serotype of Vibrio parahaemolyticus and an application thereof are provided. A novel K (capsular antigen) serotype of Vibrio parahaemolyticus, which was deposited at the China General Microbiological Culture Collection Center (Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing) on Feb. 20, 2019, with a deposit number of CGMCC No. 17249, wherein the K epitope of the Vibrio parahaemolyticus has a sequence set forth in Sequence No. 1. The novel K serum is highly specific, and can be used to conveniently and quickly detect a novel K serotype of Vibrio parahaemolyticus (O4:KUT-recAin) which has a rising infection rate in recent years. It provides important detection techniques for the pathogen diagnosis, monitoring and prevention of infectious diarrhea.
Opening claim text (preview).
What is claimed is: 1. A method for preparing a K serum with a Vibrio parahaemolyticus as an antigen, comprising: the Vibrio parahaemolyticus is seeded into a BHI medium with 3% NaCl, and cultured at 37° C. overnight; the bacteria are collected, washed twice with normal saline, and then inactivated with a normal saline solution containing 0.5% formaldehyde for 24 h, and the inactivated bacteria are then dissolved in normal saline to act as an antigen; and the K serum is prepared by injecting and immunizing an animal with the Vibrio parahaemolyticus as the antigen; wherein the Vibrio parahaemolyticus was deposited at the China General Microbiological Culture Collection Center (Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing) on Feb. 20, 2019, with a deposit number of CGMCC No. 17249, wherein the K epitope of the Vibrio parahaemolyticus has a sequence set forth in Sequence No. 1. 2. The method for preparing the K serum with a Vibrio parahaemolyticus as an antigen according to claim 1 , further comprising: healthy 12-week-old New Zealand white rabbits are selected and immunized with the inactivated Vibrio parahaemolyticus in 0.85% NaCl at a concentration of 109 CFU/ml, 4 sites for each rabbit and 250 μl for each site, and subsequently boosted once every 2 weeks in an immunization volume the same as the first immunization, 5 times in total; thereafter, whole blood is collected from the heart, and the collected whole blood is left at 37° C. for 2 h, transferred to 4° C. overnight, and then centrifuged to collect serum, which is the K serum.
from primates, e.g. man · CPC title
Bacterial isolates · CPC title
Purification, fragmentation · CPC title
inactivated (killed) · CPC title
Vibrio · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.